Literature DB >> 11369796

Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE.

S Lund-Katz1, S Wehrli, M Zaiou, Y Newhouse, K H Weisgraber, M C Phillips.   

Abstract

To understand the molecular basis for the differences in receptor-binding activity of the three common human apolipoprotein E (apoE) isoforms, we characterized the microenvironments of their LDL receptor (LDLR)-binding regions (residues 136;-150). When present in dimyristoyl phosphatidylcholine (DMPC) complexes, the 22-kDa amino-terminal fragments (residues 1;-191) of apoE3 and apoE4 bound to the LDLR with approximately 100-fold greater affinity than the 22-kDa fragment of apoE2. The pK(a) values of lysines (K) at positions 143 and 146 in the LDLR-binding region in DMPC-associated 22-kDa apoE fragments were 9.4 and 9.9 in apoE2, 9.5 and 9.2 in apoE3, and 9.9 and 9.4 in apoE4, respectively. The increased pK(a) of K146 in apoE2 relative to apoE3 arises from a reduction in the positive electrostatic potential in its microenvironment. This effect occurs because C158 in apoE2, unlike R158 in apoE3, rearranges the intrahelical salt bridges along the polar face of the amphipathic alpha-helix spanning the LDLR-binding region, reducing the effect of the R150 positive charge on K146 and concomitantly decreasing LDLR-binding affinity. The C112R mutation in apoE4 that differentiates it from apoE3 did not perturb the pK(a) of K146 significantly, but it increased the pK(a) of K143 in apoE4 by 0.4 pH unit. This change did not alter LDLR-binding affinity. Therefore, maintaining the appropriate positive charge at the C-terminal end of the receptor-binding region is particularly critical for effective interaction with acidic residues on the LDLR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369796

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions.

Authors:  Carl Frieden; Hanliu Wang; Chris M W Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-30       Impact factor: 11.205

2.  Presence of apolipoprotein C-III attenuates apolipoprotein E-mediated cellular uptake of cholesterol-containing lipid particles by HepG2 cells.

Authors:  Shin-ya Morita; Atsushi Sakurai; Minoru Nakano; Shuji Kitagawa; Tetsurou Handa
Journal:  Lipids       Date:  2010-11-16       Impact factor: 1.880

3.  Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.

Authors:  Tuyen N Tran; Malathi G Kosaraju; Shiori Tamamizu-Kato; Olayemi Akintunde; Ying Zheng; John K Bielicki; Kent Pinkerton; Koji Uchida; Yuan Yu Lee; Vasanthy Narayanaswami
Journal:  Biochemistry       Date:  2014-01-08       Impact factor: 3.162

4.  Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study.

Authors:  Yuko Yamauchi; Noriko Deguchi; Chika Takagi; Masafumi Tanaka; Padmaja Dhanasekaran; Minoru Nakano; Tetsurou Handa; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochemistry       Date:  2008-06-24       Impact factor: 3.162

5.  Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.

Authors:  P van Vliet; R G J Westendorp; P Eikelenboom; H C Comijs; M Frölich; E Bakker; W van der Flier; E van Exel
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

6.  ApoE plasma levels and risk of cardiovascular mortality in old age.

Authors:  Simon P Mooijaart; Jimmy F P Berbée; Diana van Heemst; Louis M Havekes; Anton J M de Craen; P Eline Slagboom; Patrick C N Rensen; Rudi G J Westendorp
Journal:  PLoS Med       Date:  2006-05-09       Impact factor: 11.069

7.  Understanding Dengue Virus Capsid Protein Interaction with Key Biological Targets.

Authors:  André F Faustino; Ivo C Martins; Filomena A Carvalho; Miguel A R B Castanho; Sebastian Maurer-Stroh; Nuno C Santos
Journal:  Sci Rep       Date:  2015-07-10       Impact factor: 4.379

8.  Cellular Uptake and Clearance of Oxidatively-modified Apolipoprotein E3 by Cerebral Cortex Endothelial Cells.

Authors:  Siobanth Cruz; Vasanthy Narayanaswami
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

9.  Links between copper and cholesterol in Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Sharon La Fontaine
Journal:  Front Physiol       Date:  2013-05-16       Impact factor: 4.566

10.  Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma.

Authors:  M A Rajora; L Ding; M Valic; W Jiang; M Overchuk; J Chen; G Zheng
Journal:  Chem Sci       Date:  2017-05-23       Impact factor: 9.825

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.